ANNX

Annexon, Inc.

4.940

+0.420+9.29%

After Hours: 5.10 +0.16 +3.24%19:44 06/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.540/4.520

TODAY RANGE4.540-4.960

VOL2.38M

MARKET CAP809.38M

52 WEEK RANGE1.850-7.18

AVG VOL (3M)2.57M

% TURNOVER1.45%

TURNOVER--

P/E (TTM)-4.0642

% RANGE9.29%

EPS(TTM)-1.2155

P/E(FORWARD)-5.3696

P/B3.925

BVPS1.259

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP756.69M

SHARES OUTSTANDING163.84M

NEXT EARNINGS08/12-08/17

FREE FLOAT153.18M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·1d ago
Annexon Enters Oversold Territory (ANNX)
PUBT·1d ago
Annexon grants new hires options for 705,000 shares at $4.64 each
Reuters·1d ago
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
Barchart·1d ago
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
TipRanks·5d ago
Annexon Stockholders Approve Directors, Compensation and Share Increase
PUBT·5d ago
Annexon shareholders approve charter amendment to boost authorized common shares to 500 million
NASDAQ·06/01 15:59
Monday 6/1 Insider Buying Report: ANNX, CDNL
TipRanks·05/30 02:02
Major Insider Move Signals Growing Confidence in Annexon Biosciences
PUBT·05/29 21:21
Annexon director Muneer A. Satter acquires 613,497 common shares for $3.32 million
PUBT·05/27 12:05
Annexon CEO to join Jefferies Global Healthcare Conference fireside chat
PUBT·05/18 20:07
Annexon grants new hires options for 243,000 shares at $5.21 each
Reuters·05/18 20:05
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)
PUBT·05/18 13:55
MindWalk reports 10 partner-owned antibody programs in active Phase 1-3 trials
PUBT·05/18 12:36
MindWalk publishes Discovery-to-Clinic presentation factsheet
PUBT·05/13 20:31
Annexon director William H. Carson acquires 8,000 shares for $46,240

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-0.20%

610.92

GRDX

BIONTECH

BNTX

+1.12%

90.54

聯

聯合治療

UTHR

+0.66%

549.57

福

福泰製藥

VRTX

+1.24%

450.46

SIGA科技

SIGA

-0.92%

4.300

Moderna

MRNA

+4.45%

52.13

CRL

Medpace控股

MEDP

-0.85%

463.35

Talphera Inc

TLPH

+5.23%

0.8734

ICON plc

ICLR

+1.05%

147.72

泰

泰邦生物

CBPO

0.00%

119.99

艾

艾昆緯

IQV

+0.44%

179.17

MOLN

Arcturus醫療

ARCT

+5.17%

7.33

Gilead Sciences Inc

GILD

-0.58%

124.05

PRA健康科學

PRAH

0.00%

165.21

因

因塞特醫療

INCY

-6.04%

101.98

APVO

BioSpecifics生物

BSTC

+0.15%

88.53

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English